Colgate-Palmolive Company (NYSE:CL – Get Free Report) insider Sally Massey sold 15,851 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Colgate-Palmolive Stock Down 0.2%
Shares of NYSE CL opened at $94.18 on Tuesday. The stock has a market cap of $75.92 billion, a PE ratio of 35.95, a PEG ratio of 4.26 and a beta of 0.29. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. The business has a fifty day moving average of $82.41 and a two-hundred day moving average of $81.59.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The business’s revenue was up 5.8% on a year-over-year basis. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. Citigroup lifted their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research report on Tuesday, December 9th. Wells Fargo & Company boosted their price target on Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research note on Sunday, February 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $94.47.
Hedge Funds Weigh In On Colgate-Palmolive
Hedge funds and other institutional investors have recently made changes to their positions in the stock. HighPoint Advisor Group LLC increased its stake in Colgate-Palmolive by 0.7% in the fourth quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock valued at $1,255,000 after purchasing an additional 109 shares in the last quarter. Sunpointe LLC boosted its holdings in Colgate-Palmolive by 4.0% during the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after acquiring an additional 117 shares during the last quarter. RFG Advisory LLC boosted its holdings in Colgate-Palmolive by 1.4% during the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock worth $839,000 after purchasing an additional 123 shares during the last quarter. Tiemann Investment Advisors LLC increased its position in shares of Colgate-Palmolive by 2.1% during the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after acquiring an additional 125 shares during the last quarter. Finally, Capital Advisors Inc. OK boosted its holdings in shares of Colgate-Palmolive by 1.4% in the 4th quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock worth $758,000 after buying an additional 129 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
